Literature DB >> 26085205

Ubiquitin-dependent regulation of Foxp3 and Treg function.

Joseph Barbi1, Drew M Pardoll1, Fan Pan1.   

Abstract

Regulatory T (Treg) cells are crucial enforcers of immune homeostasis. Their characteristic suppressive function largely arises from an equally unique pattern of gene expression. A complex network of factors and processes contribute to this 'signature' Treg gene expression landscape. Many of these alter the level and activity of the Treg-defining transcription factor Foxp3. As stable expression of Foxp3 is important for the ability of Treg cells to successfully prevent excessive or inappropriate immune activation, uncovering the mechanisms regulating Foxp3 level is required for the understanding and therapeutic exploitation of Tregs. While transcriptional regulation of the Foxp3 gene has been studied in depth, additional regulatory layers exist controlling the expression and activity of this key transcription factor. These include less-defined mechanisms active at the post-translational level. These pathways are just beginning to be elucidated. Here, we summarize emerging evidence for distinct, post-translationally active, ubiquitin-dependent pathways capable of controlling the activation and expression of Foxp3 and the function of Tregs. These pathways offer untapped opportunities for therapeutic fine-tuning of Tregs and their all-important restraint of the immune system.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Foxp3; Treg; post-translational regulation; ubiquitin

Mesh:

Substances:

Year:  2015        PMID: 26085205      PMCID: PMC4930875          DOI: 10.1111/imr.12312

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  162 in total

Review 1.  Protein degradation by the ubiquitin-proteasome pathway in normal and disease states.

Authors:  Stewart H Lecker; Alfred L Goldberg; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

2.  Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.

Authors:  Edwin F de Zoeten; Liqing Wang; Hong Sai; Wolfgang H Dillmann; Wayne W Hancock
Journal:  Gastroenterology       Date:  2009-10-29       Impact factor: 22.682

3.  Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells.

Authors:  Stephen R Mattarollo; Kim Steegh; Ming Li; Helene Duret; Shin Foong Ngiow; Mark J Smyth
Journal:  Immunol Cell Biol       Date:  2012-10-23       Impact factor: 5.126

Review 4.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

Authors:  Jochen Huehn; Julia K Polansky; Alf Hamann
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

5.  Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription.

Authors:  Amy Colleran; Patricia E Collins; Christine O'Carroll; Abrar Ahmed; Xicheng Mao; Bettina McManus; Patrick A Kiely; Ezra Burstein; Ruaidhrí J Carmody
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

6.  An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.

Authors:  Jaime Darce; Dipayan Rudra; Li Li; Junko Nishio; Daniela Cipolletta; Alexander Y Rudensky; Diane Mathis; Christophe Benoist
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

7.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

8.  TRAF6 is essential for maintenance of regulatory T cells that suppress Th2 type autoimmunity.

Authors:  Go Muto; Hitoshi Kotani; Taisuke Kondo; Rimpei Morita; Sanae Tsuruta; Takashi Kobayashi; Hervé Luche; Hans Joerg Fehling; Matthew Walsh; Yongwon Choi; Akihiko Yoshimura
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.

Authors:  Hyoung-Pyo Kim; Warren J Leonard
Journal:  J Exp Med       Date:  2007-06-25       Impact factor: 14.307

View more
  16 in total

Review 1.  Regulatory T cells in autoimmune disease.

Authors:  Margarita Dominguez-Villar; David A Hafler
Journal:  Nat Immunol       Date:  2018-06-20       Impact factor: 25.606

2.  Induction of CD4+CD25+Foxp3+ regulatory T cells by mesenchymal stem cells is associated with RUNX complex factors.

Authors:  Maryam Khosravi; Ali Bidmeshkipour; Ali Moravej; Suzzan Hojjat-Assari; Sina Naserian; Mohammad Hossein Karimi
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

3.  Ubiquitin-Dependent Regulation of Treg Function and Plasticity.

Authors:  Yi Dong; Fan Pan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Reciprocal Regulation of Glycolysis-Driven Th17 Pathogenicity and Regulatory T Cell Stability by Cdc42.

Authors:  Khalid W Kalim; Jun-Qi Yang; Yuan Li; Yan Meng; Yi Zheng; Fukun Guo
Journal:  J Immunol       Date:  2018-02-12       Impact factor: 5.422

5.  From trash collectors to guardians of cell signaling and immune homeostasis.

Authors:  Averil Ma
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

6.  A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma.

Authors:  Ruihua Fang; Muhammad Iqbal; Lin Chen; Jing Liao; Jierong Luo; Fanqin Wei; Weiping Wen; Wei Sun
Journal:  Aging (Albany NY)       Date:  2021-04-17       Impact factor: 5.682

7.  FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-III.

Authors:  Minlin Jiang; Chunyan Wu; Liping Zhang; Chenglong Sun; Hao Wang; Yi Xu; Hui Sun; Jun Zhu; Wencheng Zhao; Qiyu Fang; Jia Yu; Peixin Chen; Shengyu Wu; Zixuan Zheng; Yayi He; Caicun Zhou
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

Review 8.  Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development.

Authors:  Yousef Zakharia; Arup Bhattacharya; Youcef M Rustum
Journal:  Oncotarget       Date:  2018-01-23

Review 9.  Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia.

Authors:  Sena Kim; Srikanth Santhanam; Sora Lim; Jaebok Choi
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

Review 10.  The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL).

Authors:  Helen Ma; Ardy Davarifar; Jennifer E Amengual
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 4.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.